These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11478354)

  • 1. Fluoro-2-deoxy-glucose positron emission tomography in oncology: are we there yet?
    Khafagi FA
    Intern Med J; 2001; 31(1):3-4. PubMed ID: 11478354
    [No Abstract]   [Full Text] [Related]  

  • 2. Current status of positron emission tomography in oncology.
    Scott AM
    Intern Med J; 2001; 31(1):27-36. PubMed ID: 11478353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of tumor response using [18F]-2-fluoro-2-deoxy-D-glucose and positron-emission tomography.
    Lammertsma AA
    J Clin Pharmacol; 2001 Jul; 41(S7):104S-106S. PubMed ID: 11452713
    [No Abstract]   [Full Text] [Related]  

  • 4. The stage is set for the diffusion of positron emission tomography (PET) in oncology.
    Morris JG
    Med J Aust; 1999 Nov; 171(10):527-8. PubMed ID: 10816702
    [No Abstract]   [Full Text] [Related]  

  • 5. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum.
    Whiteford MH; Whiteford HM; Yee LF; Ogunbiyi OA; Dehdashti F; Siegel BA; Birnbaum EH; Fleshman JW; Kodner IJ; Read TE
    Dis Colon Rectum; 2000 Jun; 43(6):759-67; discussion 767-70. PubMed ID: 10859074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Guidelines for tumor diagnosis with (F-18)-fluorodeoxyglucose (FDG)].
    Knapp WH
    Nuklearmedizin; 1999; 38(6A):267-9. PubMed ID: 10510829
    [No Abstract]   [Full Text] [Related]  

  • 7. [Added value of positron emission tomography with fluoro-18-deoxyglucose as the tracer (FDG-PET) in clinical problem cases in oncology].
    Soepenberg O
    Ned Tijdschr Geneeskd; 2000 Oct; 144(41):1979-80. PubMed ID: 11048563
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical oncological applications of Positron Emission Tomography (PET) using fluorine-18-fluoro-2-deoxy-D-glucose.
    Giorgetti A; Volterrani D; Mariani G
    Radiol Med; 2002 Apr; 103(4):293-318. PubMed ID: 12107381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [2002 Standards, Options and Recommendations for the use of [18F]-FDG (PET-FDG) in cancerology].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S1-109. PubMed ID: 12744225
    [No Abstract]   [Full Text] [Related]  

  • 10. PET FDG studies in oncology.
    Hawkins RA; Hoh CK
    Nucl Med Biol; 1994 Jul; 21(5):739-47. PubMed ID: 9241650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of positron emission tomography in oncology.
    Scott AM
    Australas Radiol; 2002 Jun; 46(2):154-62. PubMed ID: 12060153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic value of positron emission tomography (PET) in clinical oncology].
    Czech N; Brenner W; Kampen WU; Henze E
    Dtsch Med Wochenschr; 2000 May; 125(18):565-7. PubMed ID: 10835983
    [No Abstract]   [Full Text] [Related]  

  • 13. Summary of the Standards, Options and Recommendations for the use of positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose (FDP-PET scanning) in oncology (2002).
    Bourguet P; Blanc-Vincent MP; Boneu A; Bosquet L; Chauffert B; Corone C; Courbon F; Devillers A; Foehrenbach H; Lumbroso JD; Mazselin P; Montravers F; Moretti JL; Talbot JN;
    Br J Cancer; 2003 Aug; 89 Suppl 1(Suppl 1):S84-91. PubMed ID: 12915907
    [No Abstract]   [Full Text] [Related]  

  • 14. [Positron emission tomography in oncology].
    Hatazawa J; Higuchi I; Nakamura H
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):748-54. PubMed ID: 12852339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-fluoro-2-deoxy-D-glucose-positron emission tomography (PET)/PET-computed tomography in carcinoma of the cervix.
    Kumar R; Dadparvar S
    Cancer; 2007 Oct; 110(8):1650-3. PubMed ID: 17763373
    [No Abstract]   [Full Text] [Related]  

  • 16. [The value of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG PET) in diagnosis of neoplastic diseases].
    Ruiz Hernández G; Romero de Avila Y Avalos C; Carreras Delgado JL
    Med Clin (Barc); 2005 Feb; 124(6):229-36. PubMed ID: 15737307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Imaging of cancer using positron emission tomography].
    Goldman S; Vanderhoeft A; Lebeau de Hemricourt E; Dusart M; Damhaut P; Wikler D
    Rev Med Brux; 1999 Sep; 20(4):A365-8. PubMed ID: 10523925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Positron-emission tomography in oncology].
    Carreras Delgado JL
    An R Acad Nac Med (Madr); 1997; 114(2):445-70; discussion 470-8. PubMed ID: 9412252
    [No Abstract]   [Full Text] [Related]  

  • 19. Positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose in oncology. Part II. The clinical value in detecting and staging primary tumours.
    Ak I; Stokkel MP; Pauwels EK
    J Cancer Res Clin Oncol; 2000 Oct; 126(10):560-74. PubMed ID: 11043393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography: clinical applications in oncology. Part 1.
    Kumar R; Nadig MR; Chauhan A
    Expert Rev Anticancer Ther; 2005 Dec; 5(6):1079-94. PubMed ID: 16336099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.